Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Pelvic inflammatory disease natural history

Introduction

Overview

Overview

The overall prognosis of PID is good. Timely, appropriate treatment often prevents serious complications such as ectopic pregnancy, infertility, hydrosalpinx, and chronic pelvic pain.

Natural history

Natural history

If left untreated, PID may lead to infertility in approximately 16% of affected women.[1] It may progress to adjacent organ involvement or even peritonitis.

Prognosis

Prognosis

The overall prognosis of PID is good if patients are treated within 3 days of the onset of symptoms onset, though clinical improvement cannot guarantee protection against infertility.[2]

Factors that predict poor prognosis include:[3]

Complications

Complications

Chronic pelvic pain

Infertility

Ectopic pregnancy

Hydrosalpinx

Fitz Hugh Curtis syndrome

References

References

  1. ↑ 1.0 1.1 WestrΓΆm L, Joesoef R, Reynolds G, Hagdu A, Thompson SE (1992). “Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results”. Sex Transm Dis. 19 (4): 185–92. PMIDΒ 1411832.
  2. ↑ Ross J (2004). “Pelvic inflammatory disease”. Clin Evid (11): 2121–7. PMIDΒ 15652102.
  3. ↑ Terao M, Koga K, Fujimoto A, Wada-Hiraike O, Osuga Y, Yano T, Kozuma S (2014). “Factors that predict poor clinical course among patients hospitalized with pelvic inflammatory disease”. J. Obstet. Gynaecol. Res. 40 (2): 495–500. doi:10.1111/jog.12189. PMIDΒ 24118399.
  4. ↑ Ness RB, Soper DE, Holley RL, Peipert J, Randall H, Sweet RL, Sondheimer SJ, Hendrix SL, Amortegui A, Trucco G, Songer T, Lave JR, Hillier SL, Bass DC, Kelsey SF (2002). “Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial”. Am. J. Obstet. Gynecol. 186 (5): 929–37. PMIDΒ 12015517.
  5. ↑ Haggerty CL, Peipert JF, Weitzen S, Hendrix SL, Holley RL, Nelson DB, Randall H, Soper DE, Wiesenfeld HC, Ness RB (2005). “Predictors of chronic pelvic pain in an urban population of women with symptoms and signs of pelvic inflammatory disease”. Sex Transm Dis. 32 (5): 293–9. PMIDΒ 15849530.
  6. ↑ Cates W, Joesoef MR, Goldman MB (1993). “Atypical pelvic inflammatory disease: can we identify clinical predictors?”. Am. J. Obstet. Gynecol. 169 (2 Pt 1): 341–6. PMIDΒ 8362945.
  7. ↑ Svenstrup HF, Fedder J, Kristoffersen SE, Trolle B, Birkelund S, Christiansen G (2008). “Mycoplasma genitalium, Chlamydia trachomatis, and tubal factor infertility–a prospective study”. Fertil. Steril. 90 (3): 513–20. doi:10.1016/j.fertnstert.2006.12.056. PMIDΒ 17548070.
  8. ↑ Hillis SD, Joesoef R, Marchbanks PA, Wasserheit JN, Cates W, Westrom L (1993). “Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility”. Am. J. Obstet. Gynecol. 168 (5): 1503–9. PMIDΒ 8498436.
  9. ↑ WestrΓΆm L (1980). “Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries”. Am. J. Obstet. Gynecol. 138 (7 Pt 2): 880–92. PMIDΒ 7008604.
  10. ↑ Lepine LA, Hillis SD, Marchbanks PA, Joesoef MR, Peterson HB, Westrom L (1998). “Severity of pelvic inflammatory disease as a predictor of the probability of live birth”. Am. J. Obstet. Gynecol. 178 (5): 977–81. PMIDΒ 9609570.
  11. ↑ Kawwass JF, Crawford S, Kissin DM, Session DR, Boulet S, Jamieson DJ (2013). “Tubal factor infertility and perinatal risk after assisted reproductive technology”. Obstet Gynecol. 121 (6): 1263–71. doi:10.1097/AOG.0b013e31829006d9. PMCΒ 4292839. PMIDΒ 23812461.
  12. ↑ Brunham RC, Gottlieb SL, Paavonen J (2015). “Pelvic inflammatory disease”. N. Engl. J. Med. 372 (21): 2039–48. doi:10.1056/NEJMra1411426. PMIDΒ 25992748.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]